Follow
Ignasi Roca, PhD
Ignasi Roca, PhD
Hospital Clinic Barcelona
Verified email at clinic.ub.es
Title
Cited by
Cited by
Year
The global threat of antimicrobial resistance: science for intervention
I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ...
New microbes and new infections 6, 22-29, 2015
12702015
The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace
I Roca Subirà, P Espinal, J Vila Estapé
Frontiers in microbiology 3, 18713, 2012
4712012
Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii
Y Smani, A Fàbrega, I Roca, V Sánchez-Encinales, J Vila, J Pachón
Antimicrobial agents and chemotherapy 58 (3), 1806-1808, 2014
2222014
High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as …
J Nowak, E Zander, D Stefanik, PG Higgins, I Roca, J Vila, MJ McConnell, ...
Journal of Antimicrobial Chemotherapy 72 (12), 3277-3282, 2017
1702017
First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 β-lactamase in Klebsiella pneumoniae in Spain
C Pitart, M Solé, I Roca, A Fabrega, J Vila, F Marco
Antimicrobial agents and chemotherapy 55 (9), 4398-4401, 2011
1702011
Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS
P Espinal, H Seifert, L Dijkshoorn, J Vila, I Roca
Clinical Microbiology and Infection 18 (11), 1097-1103, 2012
1522012
CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii
I Roca, S Marti, P Espinal, P Martínez, I Gibert, J Vila
Antimicrobial agents and chemotherapy 53 (9), 4013-4014, 2009
1522009
Partial characterization of a transposon containing the tet (A) determinant in a clinical isolate of Acinetobacter baumannii
A Ribera, I Roca, J Ruiz, I Gibert, J Vila
Journal of Antimicrobial Chemotherapy 52 (3), 477-480, 2003
1232003
First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain
M Solé, C Pitart, I Roca, A Fabrega, P Salvador, L Munoz, I Oliveira, ...
Antimicrobial agents and chemotherapy 55 (9), 4402-4404, 2011
1222011
Acinetobacter dijkshoorniae sp. nov., a member of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex mainly recovered from clinical samples in …
C Cosgaya, M Marí-Almirall, A Van Assche, D Fernández-Orth, ...
International journal of systematic and evolutionary microbiology 66 (10 …, 2016
1102016
Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru
S Levy-Blitchtein, I Roca, S Plasencia-Rebata, W Vicente-Taboada, ...
Emerging microbes & infections 7 (1), 1-9, 2018
1002018
MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. seifertii and A. dijkshoorniae species
M Marí-Almirall, C Cosgaya, PG Higgins, A Van Assche, M Telli, G Huys, ...
Clinical Microbiology and Infection 23 (3), 210. e1-210. e9, 2017
932017
Automated categorization of methicillin-resistant Staphylococcus aureus clinical isolates into different clonal complexes by MALDI-TOF mass spectrometry
M Camoez, JM Sierra, MA Dominguez, M Ferrer-Navarro, J Vila, I Roca
Clinical Microbiology and Infection 22 (2), 161. e1-161. e7, 2016
872016
Molecular Characterization of blaNDM-5 Carried on an IncFII Plasmid in an Escherichia coli Isolate from a Nontraveler Patient in Spain
C Pitart, M Solé, I Roca, A Román, A Moreno, J Vila, F Marco
Antimicrobial agents and chemotherapy 59 (1), 659-662, 2015
732015
Two Different rpf Clusters Distributed among a Population of Stenotrophomonas maltophilia Clinical Strains Display Differential Diffusible Signal Factor Production …
P Huedo, D Yero, S Martínez-Servat, I Estibariz, R Planell, P Martínez, ...
Journal of bacteriology 196 (13), 2431-2442, 2014
712014
Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter
P Espinal, I Roca, J Vila
Future microbiology 6 (5), 495-511, 2011
702011
NrdI Essentiality for Class Ib Ribonucleotide Reduction in Streptococcus pyogenes
I Roca, E Torrents, M Sahlin, I Gibert, BM Sjöberg
Journal of bacteriology 190 (14), 4849-4858, 2008
702008
Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo
S Gerson, JW Betts, K Lucaßen, CS Nodari, J Wille, M Josten, S Göttig, ...
Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 01586-18, 2019
682019
Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of Acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain
N Mosqueda, P Espinal, C Cosgaya, S Viota, V Plasensia, ...
Antimicrobial agents and chemotherapy 57 (10), 5155-5157, 2013
622013
Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain
M Merino, M Poza, I Roca, MJ Barba, MD Sousa, J Vila, G Bou
Microbial Drug Resistance 20 (4), 259-263, 2014
582014
The system can't perform the operation now. Try again later.
Articles 1–20